These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2711027)

  • 1. Stereoselective disposition of nilvadipine, a new dihydropyridine calcium antagonist, in the rat and dog.
    Tokuma Y; Fujiwara T; Niwa T; Hashimoto T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1989 Feb; 63(2):249-62. PubMed ID: 2711027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective oxidation of nilvadipine, a new dihydropyridine calcium antagonist, in rat and dog liver.
    Niwa T; Tokuma Y; Nakagawa K; Noguchi H
    Drug Metab Dispos; 1989; 17(1):64-8. PubMed ID: 2566472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution and excretion of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs.
    Tokuma Y; Fujiwara T; Noguchi H
    Xenobiotica; 1987 Nov; 17(11):1341-9. PubMed ID: 3433803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels of (+)- and (-)-nilvadipine after oral dosing with racemic (+)-nilvadipine in man.
    Tokuma Y; Fujiwara T; Noguchi H
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):229-37. PubMed ID: 3659571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
    Teramura T; Watanabe T; Higuchi S; Hashimoto K
    Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereoselectivity in the metabolism of disopyramide enantiomers in rat and dog.
    Cook CS; Karim A; Sollman P
    Drug Metab Dispos; 1982; 10(2):116-21. PubMed ID: 6124395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
    Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
    Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study of benidipine hydrochloride in rats and dogs.
    Kobayashi H; Kobayashi S; Inoue A; Oka T; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1750-3. PubMed ID: 3219154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereoselective oxidation and plasma protein binding of nilvadipine, a new dihydropyridine calcium antagonist, in man.
    Niwa T; Tokuma Y; Nakagawa K; Noguchi H; Yamazoe Y; Kato R
    Res Commun Chem Pathol Pharmacol; 1988 May; 60(2):161-72. PubMed ID: 3393731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of the enantiomers of verapamil in the dog.
    Bai SA; Lankford SM; Johnson LM
    Chirality; 1993; 5(6):436-42. PubMed ID: 8398603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disposition of vildagliptin, a novel dipeptidyl peptidase 4 inhibitor, in rats and dogs.
    He H; Tran P; Yin H; Smith H; Flood D; Kramp R; Filipeck R; Fischer V; Howard D
    Drug Metab Dispos; 2009 Mar; 37(3):545-54. PubMed ID: 19074976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of nilvadipine, a new dihydropyridine calcium antagonist, in mice, rats, rabbits and dogs.
    Tokuma Y; Sekiguchi M; Niwa T; Noguchi H
    Xenobiotica; 1988 Jan; 18(1):21-8. PubMed ID: 3354229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of nimodipine. I. Communication: absorption, concentration in plasma and excretion after single administration of [14C]nimodipine in rat, dog and monkey.
    Maruhn D; Siefert HM; Weber H; Rämsch K; Suwelack D
    Arzneimittelforschung; 1985; 35(12):1781-6. PubMed ID: 4096729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereoselective metabolism of tazofelone, an anti-inflammatory bowel disease agent, in rats and dogs and in human liver microsomes.
    Clay MP; Hanssen BR; Surapaneni SS; Lindstrom TD
    Chirality; 1999; 11(3):233-40. PubMed ID: 10079502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.